ABBOTT INDIA
|
The Current P/S Ratio of ABBOTT INDIA is 8.79.
| Share Price | ₹27,829.8 | Jan 23,2026 |
| Market Cap | ₹58,999.2 Cr | |
| Sales-TTM | ₹6,714.4 Cr | TTM-Standalone Results |
| Price/Sales | 8.79x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ABBOTT INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹58,999.2 Cr] as on Jan 23,2026
(/) Sales [ ₹6,714.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 8.79x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay '8.79 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ABBOTT INDIA !
The chart below summarizes the trend in P/S Ratio of ABBOTT INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ABBOTT INDIA
PS Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 8.76x.
- ABBOTT INDIA 's operated at median p/e ratio of 8.77x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2025 at 10.19x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 7.39x.
How does ABBOTT INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ABBOTT INDIA | 6,714.4 | 8.79 | 58,999.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.12 | 391,488.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.90 | 159,415.0 |
| CIPLA LTD | 28,351.1 | 3.75 | 106,210.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.85 | 132,906.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.97 | 103,089.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.39 | 86,802.6 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.62 | 88,744.8 |
| LUPIN LTD | 24,750.7 | 3.94 | 97,624.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.02 | 65,813.5 |
| ALKEM LABORATORIES LTD | 13,890.2 | 4.95 | 68,702.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ABBOTT INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.02x |
| Max industry PS | 15.90x |
| Median industry PS | 4.95x |
| Average industry PS | 6.39x |
You may also like the below Video Courses